Local biopharmaceutical firm Adimmune Corp (國光生技) made public on Friday its intention to become the only supplier in Taiwan of a human vaccine against A(H1N1), a new influenza strain that broke out in Mexico in April.
Adimmune spokesman Kao Sheng-kai (高勝凱) made the declaration after a tender held by the Department of Health (DOH) earlier in the day for 5 million doses of the vaccine failed because only Adimmune submitted a bid.
The law governing governmental tenders requires that at least three companies submit bids for a tender to be valid.
SECOND ROUND
The DOH, however, will open a second tender next week that according to the Government Procurement Act (政府採購法) will not require a minimum number of bidders or a preset price range, Centers for Disease Control Deputy Director-General Lin Ding (林頂) said.
Kao said that his company, also known as Kuo Kwang Biotechnology Co, intends to vie for the business and become the government’s main supplier of the vaccine.
Foreign suppliers, already unable to meet demand in international markets and unlikely to be able to comply with the government’s targeted October delivery date, have not shown any desire to participate in tenders for the (A)H1N1 vaccine.
PRICE
Kao said the price of the vaccine for swine flu, which in recent months has spread around the world, has been on the rise because of increasing demand, including the US requirement of some 600 million doses.
Using the case of Novartis AG as an example, Kao said that the Switzerland-based drug company sold the vaccine at between US$8 and US$10 per dose to early buyers, but that this has recently increased to more than US$10 per dose.
Adimmune general manager Ignatius Wei (魏逸之) said the company’s price for the vaccine would be below US$10 per dose, but Kao said on Friday that the final price would be decided by the company’s board of directors.
CONDITIONS
The DOH said the government had planned to purchase the vaccine at a price of NT$200 per dose, but it would be allowed to raise its purchase price in the second tender.
The only private human vaccine manufacturing company in Taiwan said that it has purchased 8 million chicken eggs to produce the human vaccine against (A)H1N1 using chicken embryos.
Kao indicated that the company has begun the process of producing more than 1.5 doses from one egg, and he estimated Adimmune could produce between 7.5 million and 10 million doses of the vaccine with its available egg stocks.
DOSES
The DOH would purchase 10 million doses of the (A)H1N1 virus vaccine, 5 million doses of seasonal flu vaccine, and 900,000 doses of the antiviral drug Relenza this year to strengthen its anti-pandemic arsenal, Lin said.
So far, the DOH has secured 2.28 million doses of vaccine against seasonal flu, including 400,000 doses for children, Lin said.
‘SWASTICAR’: Tesla CEO Elon Musk’s close association with Donald Trump has prompted opponents to brand him a ‘Nazi’ and resulted in a dramatic drop in sales Demonstrators descended on Tesla Inc dealerships across the US, and in Europe and Canada on Saturday to protest company chief Elon Musk, who has amassed extraordinary power as a top adviser to US President Donald Trump. Waving signs with messages such as “Musk is stealing our money” and “Reclaim our country,” the protests largely took place peacefully following fiery episodes of vandalism on Tesla vehicles, dealerships and other facilities in recent weeks that US officials have denounced as terrorism. Hundreds rallied on Saturday outside the Tesla dealership in Manhattan. Some blasted Musk, the world’s richest man, while others demanded the shuttering of his
Taiwan’s official purchasing managers’ index (PMI) last month rose 0.2 percentage points to 54.2, in a second consecutive month of expansion, thanks to front-loading demand intended to avoid potential US tariff hikes, the Chung-Hua Institution for Economic Research (CIER, 中華經濟研究院) said yesterday. While short-term demand appeared robust, uncertainties rose due to US President Donald Trump’s unpredictable trade policy, CIER president Lien Hsien-ming (連賢明) told a news conference in Taipei. Taiwan’s economy this year would be characterized by high-level fluctuations and the volatility would be wilder than most expect, Lien said Demand for electronics, particularly semiconductors, continues to benefit from US technology giants’ effort
ADVERSARIES: The new list includes 11 entities in China and one in Taiwan, which is a local branch of Chinese cloud computing firm Inspur Group The US added dozens of entities to a trade blacklist on Tuesday, the US Department of Commerce said, in part to disrupt Beijing’s artificial intelligence (AI) and advanced computing capabilities. The action affects 80 entities from countries including China, the United Arab Emirates and Iran, with the commerce department citing their “activities contrary to US national security and foreign policy.” Those added to the “entity list” are restricted from obtaining US items and technologies without government authorization. “We will not allow adversaries to exploit American technology to bolster their own militaries and threaten American lives,” US Secretary of Commerce Howard Lutnick said. The entities
Minister of Finance Chuang Tsui-yun (莊翠雲) yesterday told lawmakers that she “would not speculate,” but a “response plan” has been prepared in case Taiwan is targeted by US President Donald Trump’s reciprocal tariffs, which are to be announced on Wednesday next week. The Trump administration, including US Secretary of the Treasury Scott Bessent, has said that much of the proposed reciprocal tariffs would focus on the 15 countries that have the highest trade surpluses with the US. Bessent has referred to those countries as the “dirty 15,” but has not named them. Last year, Taiwan’s US$73.9 billion trade surplus with the US
RSS